The chain says it is exploring concepts including grilled items aimed at GLP-1 users, a sign of how the drugs are shifting food businesses.
Recap by typeshit. Post by Facebook on Facebook.
Ahead of results, Kalkine looks at how costly late-stage trials for Amgen's monthly obesity shot MariTide weigh on the outlook.
A short post says demand for GLP-1s, psychedelics and testosterone is meeting commercial interests, calling it a big shift.
A beauty take that waves off pricey LA peptide and salmon sperm serums, saying better anti-aging habits are found closer to home.
LLY reached a fresh record while many tech stocks keep swinging, and the post weighs whether investors should take some profits.
Up to half of participants in the two trials of the experimental drug ended up with only mild sleep apnea, per the post.
Health minister Dzulkefly says the government did not set aside dedicated 2026 budget funds for the two GLP-1 treatments.
Loading…